首页> 外文期刊>Journal of bacteriology >Site-directed mutation of the Escherichia coli ada gene: effects of substitution of methyl acceptor cysteine-321 by histidine in Ada protein.
【24h】

Site-directed mutation of the Escherichia coli ada gene: effects of substitution of methyl acceptor cysteine-321 by histidine in Ada protein.

机译:大肠杆菌ada基因的定点突变:Ada蛋白中组氨酸取代甲基受体半胱氨酸321的作用。

获取原文
           

摘要

Oligodeoxynucleotide-mediated mutagenesis of the ada gene of Escherichia coli was used to produce two mutant Ada proteins. In mutant I the methyl acceptor Cys-321 for O6-methylguanine was replaced by histidine; and in mutant II the positions of Cys-321 and His-322 of the wild-type protein were inverted. Neither mutant protein had O6-methylguanine-DNA methyltransferase activity, but both retained the phosphotriester-DNA methyltransferase activity involving methyl group transfer to Cys-69. Under the control of the endogenous promoter, synthesis of mutant I protein was undetectable before or after adaptation treatment with promoter, synthesis of mutant I protein was undetectable before or after adaptation treatment with N-methyl-N'-nitro-N-nitrosoguanidine. This appeared to be due to both inhibition of transcription of the mutant gene and degradation of the synthesized protein. On the other hand, mutant II protein was inducible by N-methyl-N'-nitro-N-nitrosoguanidine, although to a smaller extent than the wild-type protein was, and the phosphotriester-DNA methyltransferase activity appeared to reside in 24- to 30-kilodalton cleavage products. Mutant I protein could be produced under lac promoter control, and its cleavage products, unlike those of mutant II protein, tended to aggregate. These results indicate that (i) Cys-321 cannot be replaced or transposed with the nucleophilic amino acid histidine for O6-methylguanine-DNA methyltransferase function, (ii) single amino acid replacement or transposition at the O6-methylguanine methyl acceptor site can have a profound effect on the in vivo stability and regulatory function of the Ada protein, and (iii) the integrity of the protein may not be absolutely needed for its transcription-activation function.
机译:寡核苷酸的大肠杆菌ada基因的寡聚脱氧核苷酸介导的诱变用于产生两个突变的Ada蛋白。在突变体Ⅰ中,O6-甲基鸟嘌呤的甲基受体Cys-321被组氨酸取代;在突变体II中,野生型蛋白的Cys-321和His-322的位置颠倒了。两种突变蛋白均不具有O6-甲基鸟嘌呤-DNA甲基转移酶活性,但是都保留了涉及甲基转移至Cys-69的磷酸三酯-DNA甲基转移酶活性。在内源性启动子的控制下,在用启动子进行适应性处理之前或之后无法检测到突变体I蛋白的合成,在用N-甲基-N'-硝基-N-亚硝基胍进行适应性处理之前或之后无法检测到突变体I蛋白的合成。这似乎是由于抑制了突变基因的转录和合成蛋白的降解。另一方面,突变型II蛋白可被N-甲基-N'-硝基-N-亚硝基胍诱导,尽管程度小于野生型蛋白,并且磷酸三酯-DNA甲基转移酶活性似乎位于24位。到30千达尔顿的裂解产物。突变型I蛋白可以在lac启动子的控制下产生,其裂解产物与突变型II蛋白不同,倾向于聚集。这些结果表明(i)Cys-321不能被亲核氨基酸组氨酸替换或转位以实现O6-甲基鸟嘌呤-DNA甲基转移酶的功能,(ii)在O6-甲基鸟嘌呤甲基受体位点的单个氨基酸替换或转位可以具有Ada蛋白对Ada蛋白的体内稳定性和调节功能具有深远的影响,并且(iii)该蛋白的转录激活功能可能并非绝对需要该蛋白的完整性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号